Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.

Head and neck neoplasms Radiotherapy Smoking Squamous cell carcinoma Tobacco Toxicity

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
09 May 2024
Historique:
received: 28 12 2023
revised: 09 04 2024
accepted: 03 05 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 10 5 2024
Statut: aheadofprint

Résumé

The association between smoking and acute radiation toxicities of head and neck cancer (HNC) is currently unproven. The aim of the study was to compare the occurrence of acute severe toxicity between active and non-active smokers treated for HNC by radiotherapy. A prospective monocentric cohort study included patients treated by (chemo)radiotherapy for HNC from January 2021 to January 2023. Smoking status was recorded. Patients underwent a medical exam weekly during the radiotherapy to report acute toxicities according to the Common Terminology Criteria for Adverse Effects system version 5.0. Primary endpoint was the occurrence of at least one grade ≥ 3 acute toxicity among mucositis, dysphagia and dermatitis. Among the 102 patients included, 27.4 % were active smokers, 58.8 % were former smokers and 13.7 % had never smoked. Regarding toxicity, 23.5 % (n = 24) patients experienced severe mucositis, 37.2 % (n = 38) severe dysphagia, 13.7 % (n = 14) severe dermatitis and 54.9 % (n = 56) experienced at least one of them. Occurrence of severe acute toxicity was not statistically associated with smoking during radiotherapy (64.3 % among active smokers versus 51.3 % among non-active smokers; p = 0.24). On multivariate analysis, concurrent chemotherapy (87.5 % vs 65.2 %; OR = 5.04 [1.64-15.52]; p = 0.004) and 2.12 Gy versus 2 Gy fractionation schedule (64.3 % vs 41.3 %; OR = 2.53 [1.09-5.90]; p = 0.03) were significantly associated with severe acute toxicity. This study did not find an association between smoking during radiotherapy for HNC and occurrence of severe acute toxicities.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
The association between smoking and acute radiation toxicities of head and neck cancer (HNC) is currently unproven. The aim of the study was to compare the occurrence of acute severe toxicity between active and non-active smokers treated for HNC by radiotherapy.
MATERIALS AND METHODS METHODS
A prospective monocentric cohort study included patients treated by (chemo)radiotherapy for HNC from January 2021 to January 2023. Smoking status was recorded. Patients underwent a medical exam weekly during the radiotherapy to report acute toxicities according to the Common Terminology Criteria for Adverse Effects system version 5.0. Primary endpoint was the occurrence of at least one grade ≥ 3 acute toxicity among mucositis, dysphagia and dermatitis.
RESULTS RESULTS
Among the 102 patients included, 27.4 % were active smokers, 58.8 % were former smokers and 13.7 % had never smoked. Regarding toxicity, 23.5 % (n = 24) patients experienced severe mucositis, 37.2 % (n = 38) severe dysphagia, 13.7 % (n = 14) severe dermatitis and 54.9 % (n = 56) experienced at least one of them. Occurrence of severe acute toxicity was not statistically associated with smoking during radiotherapy (64.3 % among active smokers versus 51.3 % among non-active smokers; p = 0.24). On multivariate analysis, concurrent chemotherapy (87.5 % vs 65.2 %; OR = 5.04 [1.64-15.52]; p = 0.004) and 2.12 Gy versus 2 Gy fractionation schedule (64.3 % vs 41.3 %; OR = 2.53 [1.09-5.90]; p = 0.03) were significantly associated with severe acute toxicity.
CONCLUSION CONCLUSIONS
This study did not find an association between smoking during radiotherapy for HNC and occurrence of severe acute toxicities.

Identifiants

pubmed: 38729039
pii: S1368-8375(24)00151-9
doi: 10.1016/j.oraloncology.2024.106833
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106833

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

C Invernizzi (C)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France; Health Division, University of Reims Champagne-Ardenne, 51100 Reims, France.

A Da Silva Ribeiro Mota (A)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France.

C Barbe (C)

Department of Biostatistics and Health Economics, University of Reims Champagne-Ardenne, CURRS, 51100 Reims, France.

L Bouazzi (L)

Department of Biostatistics and Health Economics, University of Reims Champagne-Ardenne, CURRS, 51100 Reims, France.

O Marques (O)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France.

L Munschi (L)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France.

C Marchand-Crety (C)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France.

N Jacquin (N)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France; Health Division, University of Reims Champagne-Ardenne, 51100 Reims, France.

X Dubernard (X)

Health Division, University of Reims Champagne-Ardenne, 51100 Reims, France; Department of Otorhinolaryngology Head and Neck Surgery, Robert Debré University Hospital Center, 51100 Reims, France.

A Beddok (A)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France; Health Division, University of Reims Champagne-Ardenne, 51100 Reims, France.

C Lasset (C)

Department of Prevention and Genetic Epidemiology, Léon Bérard Center, 69 373 Lyon Cedex 08, France.

N Assouly (N)

Department of Surgery, Institut Godinot, 51100 Reims, France.

S Vignot (S)

Department of Onco-Radiotherapy, Institut Godinot, 51100 Reims, France; Health Division, University of Reims Champagne-Ardenne, 51100 Reims, France.

E Brenet (E)

Health Division, University of Reims Champagne-Ardenne, 51100 Reims, France; Department of Otorhinolaryngology Head and Neck Surgery, Robert Debré University Hospital Center, 51100 Reims, France. Electronic address: ebrenet@chu-reims.fr.

Classifications MeSH